COVID-19

Leading health systems through the No Normal.

With the end of the novel coronavirus nowhere in sight, the pandemic’s impact on our society, and the industry and organizations changing every day, we find ourselves in what we call the era of the No Normal. If you’re looking for help in how to succeed as a health system marketer or communicator in this time of uncertainty, you’ve come to the right place. Since mid-March, when the pandemic first significantly hit the U.S., we have stayed on top of the crisis by conducting consumer surveys, publishing our take on the latest news, providing insights and advice, and connecting you with your peers through podcasts and webinars. If there’s something you’re looking for and can’t find below, let us know.

Content Type
November 19, 2020

Our new report includes four key findings to help influence your approach to addressing internal and external concerns surrounding the COVID-19 vaccine.

November 16, 2020

Learn about these three predictions for 2021 on consumerism, the “value crisis,” and the evolving role of health system brands in our upcoming webinar series. Join us for one, two, or all three webinars — just make sure you join us. 

November 12, 2020

In this episode of The No Normal Show, we welcome ReviveHealth's CEO, Brandon Edwards to discuss the impact of the election and what that means for the hospital industry.

November 5, 2020

In this episode of The No Normal Show, we dive deep into our national survey on how consumers feel about the COVID-19 vaccine and the implications for health system marketers and communicators.​​​​​

October 29, 2020

In this episode of the No Normal Show, we welcome Kendra Calhoun, SVP of Strategic Marketing, Communications, and PR at Avera Health. Kendra discussed with us their approach to consumer centricity and how COVID-19 has been a forcing function for their 35 hospital health system. 

October 29, 2020

In our latest national consumer report, we surveyed consumers to learn about when they expect a vaccine and who they’ll trust when it comes to determining its safety and effectiveness.